We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genomic Surveillance Algorithm Improves Early Detection of Emerging Variants

By LabMedica International staff writers
Posted on 08 Jul 2026

Genomic surveillance is essential for detecting viral variants before they spread widely, yet many public health systems face high costs, uneven capacity, and computational barriers. More...

Existing analytic pipelines often struggle to scale across regions while preserving critical transmission links, slowing response during outbreaks. Lower-resource settings are disproportionately affected by these limitations. A new study shows a scalable algorithm that accelerates and lowers the cost of genomic surveillance.

Researchers at Texas A&M University developed the Iterative Block Particle Filter (IBPF), a computational framework designed to optimize global genomic surveillance. The framework aims to strengthen local, community-based sequencing capacity while preserving the regional interactions needed to track variant spread. The work was carried out with collaborators from multiple international institutions.

IBPF builds on the particle filter, also known as the Sequential Monte Carlo (SMC) method, which is widely used but hampered by the “curse of dimensionality” when applied to high-dimensional spatial networks. The new approach uses an iterative scheme in which the output from one data block becomes the input for the next, enabling localized updates without fragmenting critical connections between neighboring regions and travel hubs. By maintaining dependencies across spatial units while controlling filtering error locally, IBPF scales to high-dimensional spatiotemporal data common in pathogen surveillance.

In the study, the team implemented large-scale multi-strain models using real-world inputs, including epidemiological records, vaccine information, and high-resolution international air travel data. The framework tracked dozens of regions and multiple viral strains and outperformed common filtering algorithms. Notably, it reduced the time between detecting a disease variant and sequencing it. 

The results indicate that surveillance resources can be prioritized toward major international travel hubs, a strategy the authors note may be especially useful where long-term, large-scale sequencing efforts are not feasible. The paper, “Optimizing global genomic surveillance for early detection of emerging SARS-CoV-2 variants,” was published in Nature Communications.

Beyond COVID-19, the authors state that IBPF is compatible with more general systems and could support broader surveillance and forecasting applications. They also note the methodology’s relevance to other dynamic networks in which complex interactions evolve over time. The research group has made its code publicly available.

“In the machine learning community, many algorithms are designed to perform well only on specific test data sets. Our approach is different because we have theoretical performance guarantee that it works reliably across broad spatiotemporal data,” said Patricia Ning, assistant professor in the Department of Statistics at Texas A&M University.

“If we can optimize the allocation, we can spend money more efficiently. That would allow us to detect new variants much earlier without increasing the budget,” said Jifan Li, doctoral candidate in the Department of Statistics at Texas A&M University.

Related Links
Texas A&M University


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.